Neuland Laboratories Limited 11th Floor, (5th Office Level), Phoenix IVY Building, Plot No. 573A·fil, Road No.82, Jubilee Hills, Hyderabad-500033,Telangana, India
Tel :04067611600/67611700 Email: neuiand@neulandlabs.com www.neulandlabs.com
Sub: Clarification on spurt in volume of shares traded Ref: Your letter No. NSE/CM/Surveillance/12330 dated September 22, 2022
We refer to the afore-mentioned letter seeking clarification on spurt in volume of shares of the Company traded across Exchanges, in the recent past.
We would like to reiterate that our Company has been disclosing and will continue to disclose all the necessary information's/disclosures in accordance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, within the stipulated timelines and has not withheld any material information/ event that in our opinion would have a bearing on the volume behavior in our scrip.
Further, we request you to note that the equity shares of the Company are freely traded on the Stock Exchanges and the Company will not be in a position to comment on the movement of shares traded on the Exchanges.
We would like to reiterate that our Company is committed to compliance with the Listing Regulations and any information, likely to have bearing on the shares traded would be disclosed to the stock exchanges from time to time.
This is for your information and records.
Thanking you
Yours Sincerely,
For Neuland Laboratories Limited
SARADA BHAMIDIPATI
Digitally signed by SARADA BHAMIDIPATI Date: 2022.09.22 18:09:40 +05'30'
Sarada Bhamidipati Company Secretary ft Compliance Officer
Cc: BSE Limited, Dalal Street, Mumbai - 400 001
Registered Office: 11th Floor, {5th Office Level), Phoeni• IVY Building, Plot No. 573A-lfl, RoadNo.82, Jubilee Hills, Hyderabad-500033,Telangana, India
I
CIN No. LBSl9STGI 984PLCOo4393
Attachments
Original Link
Original Document
Permalink
Disclaimer
Neuland Laboratories Ltd. published this content on 26 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 September 2022 13:54:01 UTC.
Neuland Laboratories Limited is an India-based company, which is engaged in manufacturing and selling of bulk drugs. The Company caters to both domestic and international markets. It manufactures active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industryâs chemistry needs. The Company provide solutions across the full range of the pharmaceutical industryâs chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company operates through a single segment, manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services.
NEULAND LABORATORIES LIMITED 
